Recent News

By Region: Europe

Global burden of dengue is triple current estimates

(EurekAlert) The global burden of dengue infection is more than triple current estimates from the World Health Organization, according to a multinational study published today in the journal ‘Nature’. The research has created the first detailed and up-to-date map of dengue distribution worldwide, enabling researchers to estimate the total numbers of people affected by the Read More »

April 8, 2013
| Filed under Europe, Public Health, and Research
Share

New Foot and Mouth vaccine

(BBCNews) Researchers based in the UK have developed a new type of vaccine for the cattle disease Foot and Mouth. As the new vaccine is not based on a live virus it is much easier to distinguish between vaccinated animals and those infected with the disease. In addition the vaccine does not require refrigeration, making Read More »

April 5, 2013
| Filed under Europe and Countermeasures
Share

New foot-and-mouth vaccine signals huge advance in global disease control

(MedicalXpress) They have used a new method to produce a vaccine that doesn’t rely on inactivating the live, infectious virus which causes the disease – and is therefore much safer to produce. Instead the vaccine consists of empty virus shells that have been produced synthetically, and are designed to produce an immune response that protects Read More »

April 1, 2013
| Filed under Europe, Countermeasures, Public Health, and Research
Share

Livestock-to-Human MRSA Transmission Confirmed

(FoodSafetyNews) Using whole genome sequencing, scientists have found conclusive evidence that a type of methicillin-resistant Staphylococcus aureus (MRSA) that caused human infections in Denmark came from livestock – adding to concerns that food animals are a significant MRSA reservoir for human infections. While previous research has suggested that MRSA transfers from animals to humans, including Read More »

March 29, 2013
| Filed under Europe and Public Health
Share

“New” Infectious Diseases: Successful Vaccine Developments At Themis Bioscience

(MedicalNewsToday) The Viennese biotech boutique Themis has reported rapid progress in the development of two highly efficient vaccines against Dengue and Chikungunya fever. In the just concluded preclinical studies, the two vaccine candidates, based on a technology by the Parisian Pasteur Institute, displayed exceedingly good efficacy. With a single vaccination against Chikungunya it was possible Read More »